Home
Venrock Healthcare Capital Partners III reported a 7.1% stake in enGene Therapeutics ENGN · 4,771,414 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.1%
- Last report
- 9.9% · filed 25/02/14
- Shares held
- 4,771,414 sh
- Class
- Common Shares
- Event date
- 25/12/31
- Filed
- 26/02/17
7.1% stake · −2.8pp from the last report
- Stake
- 7.1%
- Last report
- 9.9%
- Since last report
- −2.8pp
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Venrock Healthcare Capital Partners III's other 5% stake reports
- Venrock Healthcare Capital Partners III
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
5.6% stake
5,555,047 sh
5.6% stake
Filed 09/21
- Venrock Healthcare Capital Partners III
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
9.9% stake
4,552,277 sh
9.9% stake
Filed 09/15
- Venrock Healthcare Capital Partners III
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
4.7% stake
1,574,892 sh
4.7% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
7.4% stake
4,556,952 sh
7.4% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
8.3% stake
5,145,330 sh
8.3% stake
Filed 08/14
